ID   MP 4112
AC   CVCL_A5IS
DR   Wikidata; Q107116389
RX   Patent=EP0368662B1;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2128.
CC   Selected for resistance to: ChEBI; CHEBI:472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3732 ! KR-12
CA   Hybrid cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
RX   Patent=EP0368662B1;
RA   Fukuda T., Okuya H., Kono N., Kuroiwa Y.;
RT   "Parent cell lines for producing human hybridomas.";
RL   Patent number EP0368662B1, 14-Sep-1994.
//